| 标题 |
Targeting EP2 overcomes osimertinib-tolerant persisters through metabolic and inflammatory reprogramming in non-small cell lung cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:International Immunopharmacology 作者:Haiyang Yu; Ling Lu; Xuecheng Hu; Qijuan Wang; 魏晶晶; et al 出版日期:2026-08-26 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)